Target intelligence / Profile preview

RNA, U6 small nuclear 560, pseudogene (RNU6-560P)

Target
RNU6-560P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNU6-560P is a non-functional, processed pseudogene derived from the gene encoding U6 small nuclear RNA (U6 snRNA). U6 snRNA is a highly conserved non-coding RNA that forms part of the spliceosomal machinery necessary for the splicing of pre-mRNA in eukaryotic nuclei[1][3]. Numerous U6 snRNA pseudogenes exist in mammalian genomes, typically lacking promoter elements or other sequences required for expression, and thus do not contribute to splicing or have independent biological activity[3][4]. Pseudogenes like RNU6-560P are generally considered "genomic fossils" rather than true molecular targets or active regulators[4]. There is currently no evidence of therapeutic, diagnostic, or pharmacological relevance for RNU6-560P. *Additional context:* - Functional U6 snRNA is essential for the major spliceosome's catalytic activity but pseudogenes do not contribute to spliceosome function[1][3]. - Most U6-derived pseudogenes are not transcribed, and even when RNA is made, it is typically unstable and non-functional[3][4]. - Pseudogenes are sometimes co-opted for regulatory roles by the genome (as in some long non-coding RNAs[4]), but there is no such evidence for RNU6-560P. This entry does not represent a true drug target, therapeutic receptor, or disease biomarker. The entity is best classified as a pseudogene of U6 small nuclear RNA.

Other names
RNU6-560PRNA, U6 small nuclear 560, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 560, pseudogene (RNU6-560P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 560, pseudogene (RNU6-560P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call